Literature DB >> 19888984

Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.

Alberto Breda1, Eric G Treat, Leah Haft-Candell, John T Leppert, Jonathan D Harper, Jonathan Said, Steven Raman, Robert B Smith, Arie S Belldegrun, Peter G Schulam.   

Abstract

OBJECTIVE: To prospectively determine the accuracy of 14-, 18- and 20-G core needle biopsies to render the appropriate histological diagnosis of solid, enhancing renal masses, using a controlled, ex-vivo biopsy technique. PATIENTS AND METHODS: From March 2007 to September 2007, 31 patients undergoing partial or radical nephrectomy were randomly selected for biopsy. After extirpative surgery, three ex-vivo biopsies were taken from each lesion with 14-, 18- and 20-G biopsy needles. One experienced genitourinary pathologist, unaware of patient identifiers and final pathology results, determined the biopsy histology and tumour grade, based on standard haematoxylin and eosin (H&E) techniques and immunohistochemistry.
RESULTS: The final pathological evaluation classified 21 masses (68%) as clear cell renal cell carcinoma (RCC), three (10%) as papillary RCC, three (10%) as chromophobe RCC, three (10%) as oncocytoma and one (3%) as a benign lymphoid infiltrate. The biopsy histology correlated with the final pathology in 29/31 cases (94%) with the 14-G, 30/31 cases (97%) with the 18-G and 25/31 cases (81%) with the 20-G needles. In two cases chromophobe RCC was misdiagnosed with oncocytoma, and vice versa.
CONCLUSION: In this study a minimum of an 18-G biopsy needle was the most accurate in determining the histological diagnosis. Clear cell and papillary RCCs were accurately diagnosed on biopsy using an 18-G, whereas oncocytoma and chromophobe RCC were difficult to differentiate using standard H&E techniques and immunohistochemistry.

Entities:  

Mesh:

Year:  2009        PMID: 19888984     DOI: 10.1111/j.1464-410X.2009.08989.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  12 in total

1.  CT fluoroscopy-guided renal tumour cutting needle biopsy: retrospective evaluation of diagnostic yield, safety, and risk factors for diagnostic failure.

Authors:  Toshihiro Iguchi; Takao Hiraki; Yusuke Matsui; Hiroyasu Fujiwara; Jun Sakurai; Yoshihisa Masaoka; Hideo Gobara; Susumu Kanazawa
Journal:  Eur Radiol       Date:  2017-08-02       Impact factor: 5.315

Review 2.  The role of renal biopsy in small renal masses.

Authors:  Rodolfo Burruni; Benoit Lhermitte; Yannick Cerantola; Thomas Tawadros; Jean-Yves Meuwly; Dominik Berthold; Patrice Jichlinski; Massimo Valerio
Journal:  Can Urol Assoc J       Date:  2016-01-14       Impact factor: 1.862

3.  Concerns about renal mass biopsy.

Authors:  Alireza Ghadian
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

4.  Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma.

Authors:  F Cornelis; E Tricaud; A S Lasserre; F Petitpierre; J C Bernhard; Y Le Bras; M Yacoub; M Bouzgarrou; A Ravaud; N Grenier
Journal:  Eur Radiol       Date:  2014-08-13       Impact factor: 5.315

5.  Contrast enhanced ultrasound of renal masses.

Authors:  Andre Ignee; Bernd Straub; Gudrun Schuessler; Christoph Frank Dietrich
Journal:  World J Radiol       Date:  2010-01-28

Review 6.  Interpretation of needle biopsies of the kidney for investigation of renal masses.

Authors:  Benoît Lhermitte; Laurence de Leval
Journal:  Virchows Arch       Date:  2012-06-08       Impact factor: 4.064

Review 7.  Diagnosis and Treatment of Small Renal Masses: Where Do We Stand?

Authors:  Jerez Izquierdo Tamara; Gómez Rivas Juan; Zondervan Jeannelle Patricia; Vives Dilme Roser; Rodriguez Moisés; Enikeev Dmitry; Serrano Pascual Álvaro; Moreno Sierra Jesús
Journal:  Curr Urol Rep       Date:  2022-05-04       Impact factor: 3.092

8.  Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.

Authors:  F Cornelis; E Tricaud; A S Lasserre; F Petitpierre; J C Bernhard; Y Le Bras; M Yacoub; M Bouzgarrou; A Ravaud; N Grenier
Journal:  Eur Radiol       Date:  2014-02-21       Impact factor: 5.315

Review 9.  Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation.

Authors:  Alejandro Sanchez; Adam S Feldman; A Ari Hakimi
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

10.  To biopsy a small renal mass, or not?

Authors:  Elefterios Chatzidarellis; Andreas Skolarikos; Athanasios G Papatsoris
Journal:  Nephrourol Mon       Date:  2012-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.